Active	Status	Sponsor type	Region	Phase	Filter
10 Active 6 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fineman, Jeffrey R
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension	Recruiting	3	100	Canada, US	Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer	Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS)	Pediatric Pulmonary Hypertension	09/26	09/26
PHAR, NCT04071327: Pulmonary Hypertension Association Registry	Recruiting	N/A	3000	US		Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center	Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension	10/25	10/25
PPHNet, NCT02249923: Pediatric Pulmonary Hypertension Network () Informatics Registry	Recruiting	N/A	2500	Canada, US		University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI), Johnson & Johnson	Pulmonary Vascular Disease, Pulmonary Arterial Hypertension	12/30	12/31
Andemariam, Biree
THRIVE-131, NCT04935879: A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises	Completed	3	243	Europe, US, RoW	Inclacumab, Placebo	Pfizer	Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis	06/24	06/24
NCT02306993: Sickle Cell Hemoglobinopathies and Bone Health	Active, not recruiting	N/A	45	US	Healthy volunteers without SCT, Healthy volunteers with SCT, Volunteers with SCD	UConn Health	Sickle Cell Disease, Sickle Cell Trait	12/25	12/25
NCT06743113: Hypoxic Red Blood Cells in Sickle Cell Anemia	Not yet recruiting	N/A	48	US	Hemanext ONE System, Conventional RBCs	Hemanext, Emory University, University of Connecticut, University of Pittsburgh Medical Center, Johns Hopkins All Children's Hospital, Johns Hopkins University	Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)	02/28	06/28
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD	Terminated	N/A	262	US	Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®	Pfizer, Pfizer	Sickle Cell Disease	10/24	10/24
Jones, Sasia
PROSPECT, NCT04930445: Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD	Terminated	N/A	262	US	Oxbryta® (voxelotor) 500mg Tablets, Voxelotor, Oxbryta®	Pfizer, Pfizer	Sickle Cell Disease	10/24	10/24
Boin, Francesco
CONQUEST, NCT06195072: Platform Clinical Study for Conquering Scleroderma	Recruiting	2	400	US	Amlitelimab, BI 1015550, Placebo	Scleroderma Research Foundation, Inc., Sanofi, Boehringer Ingelheim	Interstitial Lung Disease Due to Systemic Disease, Scleroderma	11/26	11/26
Foley, Raymond
PHAR, NCT04071327: Pulmonary Hypertension Association Registry	Recruiting	N/A	3000	US		Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center	Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension	10/25	10/25